Literature DB >> 11892086

The diagnosis and treatment of Whipple's disease.

T Marth1.   

Abstract

Whipple's disease is a rare, chronic, and systemic infectious disease caused by the ubiquitously occurring bacterium Tropheryma whippelii. For two reasons, the disease represents a good example for documenting the input of modern molecular-based techniques into pathogenetic, diagnostic, and therapeutic concepts in clinical medicine. First, the unidentified and uncultivable causative organism has been characterized by novel molecular-genetic techniques. Second, in contrast to other chronic inflammatory disorders, clinical manifestations of T. whippelii infection seem to be based on reduced T-cell helper type 1 (TH1) activity. These findings have led to an improved pathophysiologic understanding of the disease and to new aspects in treatment strategies that are discussed in this paper.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11892086     DOI: 10.1007/s11882-001-0066-7

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  30 in total

1.  Tropheryma whipplei circulating in blood monocytes.

Authors:  D Raoult; H Lepidi; J R Harle
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

Review 2.  Whipple's disease: the value of upper gastrointestinal endoscopy for the diagnosis and follow-up.

Authors:  K Geboes; N Ectors; H Heidbuchel; P Rutgeerts; V Desmet; G Vantrappen
Journal:  Acta Gastroenterol Belg       Date:  1992 Mar-Apr       Impact factor: 1.316

3.  Detection of Tropheryma whippelii DNA in a patient with AIDS.

Authors:  M Maiwald; H J Meier-Willersen; M Hartmann; A von Herbay
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

4.  Treatment of refractory Whipple disease with interferon-gamma.

Authors:  T Schneider; A Stallmach; A von Herbay; T Marth; W Strober; M Zeitz
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

5.  HLA B27 and defects in the T-cell system in Whipple's disease.

Authors:  G E Feurle; B Dörken; E Schöpf; V Lenhard
Journal:  Eur J Clin Invest       Date:  1979-10       Impact factor: 4.686

6.  Whipple's disease: staging and monitoring by cytology and polymerase chain reaction analysis of cerebrospinal fluid.

Authors:  A von Herbay; H J Ditton; F Schuhmacher; M Maiwald
Journal:  Gastroenterology       Date:  1997-08       Impact factor: 22.682

7.  Immunological alterations in patients with treated Whipple's disease.

Authors:  F F Martin; J Vilseck; W O Dobbins; C E Buckley; M P Tyor
Journal:  Gastroenterology       Date:  1972-07       Impact factor: 22.682

8.  A light- and electron-microscopic study of bacterial invasion in Whipple's disease.

Authors:  W O Dobbins; J M Ruffin
Journal:  Am J Pathol       Date:  1967-08       Impact factor: 4.307

9.  Tropheryma whippelii DNA in saliva of patients without Whipple's disease.

Authors:  F Dutly; H P Hinrikson; T Seidel; S Morgenegg; M Altwegg; P Bauerfeind
Journal:  Infection       Date:  2000 Jul-Aug       Impact factor: 3.553

10.  Ultrastructure of bacilli and the bacillary origin of the macrophagic inclusions in Whipple's disease.

Authors:  M T Silva; P M Macedo; J F Moura Nunes
Journal:  J Gen Microbiol       Date:  1985-05
View more
  1 in total

1.  Isolated CNS Whipple disease with normal brain MRI and false-positive CSF 14-3-3 protein: a case report and review of the literature.

Authors:  Victor W Sung; Michael J Lyerly; Kenneth B Fallon; Khurram Bashir
Journal:  Brain Behav       Date:  2012-10-01       Impact factor: 2.708

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.